Skip to Content

Should You Bring Your Trial Master File In-House? 

A Trial Master File (TMF) is an ecosystem of documents used by monitors, auditors, assessors, and sponsors to demonstrate that a clinical trial has been conducted in compliance with Good Clinical Practice (GCP) and the approved protocol. 

The TMF is an essential quality process, enabling documentation of all activity that has been performed during the study, and ultimately, should be inspection ready at any moment. Clinical trial sponsors are often challenged with the TMF process when bringing such responsibilities in-house, often finding it difficult to keep up with staffing needs, regulations, processes, and validation required. Outsourcing also brings in its own suite of challenges. 

This article discusses the advantages, disadvantages, and challenges of bringing your TMF in-house versus contracting with a Clinical Research Organization (CRO) or other third party so you can right-size your decision for your needs. 

Bringing Your Trial Master File In-House 

Advantages 

Disadvantages 

Challenges 

Contracting with a CRO to Manage Your Trial Master File 

Advantages 

Disadvantages 

Challenges 

As you navigate your TMF approach (or transition) and consider who will fill those critical resource gaps, make sure you take the time to review the advantages and disadvantages of each potential decision, and then decide based on least amount of risk to your study and organization. 

Whether you decide to bring your TMF in-house or outsource, you will need to consider the impact on your personnel and your internal infrastructure. Successful TMF management requires careful and constant attention to every process, procedure, and guideline, all to ensure the TMF is always inspection ready. 

To learn more about Halloran’s TMF strategy and implementation approach to support inspection readiness measures, contact us.